Decoding the Immune System to Improve Health
Joined May 2020
- Tweets 134
- Following 133
- Followers 1,225
- Likes 49
32 Photos and videos
Feb 4
World Cancer Day is about progress. And progress starts with better insight.
We’re proud to work with @bmsnews to apply AI-powered immune analysis that helps researchers better understand patient responses and support smarter therapy development.
tinyurl.com/bde5uc8w
136
Jan 15
Understanding patient immune response is critical to clinical development (and difficult to do well).
We’re collaborating with @BMSnews to support immune-driven clinical development, using AMICA-OS™, our immune system AI operating system.
Read more:
tinyurl.com/425vstak
1
4
1,780
20 Nov 2025
Big news: @Immunai has won the @FierceBiotech Life Sciences Award for AI Innovation. Fierce showcased our AMICA™ platform and its success in forecasting patient response - a major step toward more precise development. tinyurl.com/3z65bp5f
1
3
203
13 Nov 2025
New in Blood Advances: our Immunai team, with Mount Sinai & Janssen R&D, identified immune features predicting long-term response to CAR T therapy in multiple myeloma.
🔗 ashpublications.org/bloodadv…
#Immunai #CART #MultipleMyeloma #Immunotherapy #PrecisionMedicine
1
3
162
3 Nov 2025
Immunai has been named a finalist in the @FierceHealth : Life Sciences Edition 2025 (AI Innovation category)! Our AMICA™, CT-OS™, and PE-OS™ platforms are driving a new wave of immune intelligence, where AI helps predict, not just treat, disease. bit.ly/3J1qPUc
1
118
16 Oct 2025
Proud to expand our work with @AstraZeneca into inflammatory bowel disease. IBD affects 10M people worldwide, with many still cycling through treatments. With Immunai’s IDE™ and AMICA™, we’re uncovering and exploring new immune targets. @FierceBiotech: tinyurl.com/48htfzzy
3
6
633
4 Sep 2025
Research in immunity can’t wait for funding. We launched the Grand Collaboration Initiative to give researchers free access to immune mapping tools: accelerating discoveries in cancer, autoimmunity, and beyond. More in @PharmaVoice tinyurl.com/mr455nr8
1
160
2 Sep 2025
Research in immunity can’t wait for funding. Immunai’s Grand Collaboration Initiative is giving researchers free access to our immune mapping tools to speed discoveries in cancer, autoimmunity, and more. tinyurl.com/3k3mk5j8
170
24 Jul 2025
Immunai’s Grand Collaboration is now open!
Single-cell immune sequencing for academic researchers to advance immune system understanding.
✔️ High-resolution, multi-omic data
🧬 Enrichment of the AMICA atlas
🗓️ Applications due by Oct 1, 2025
#scRNAseq #Immunai #AcademicResearch
1
1
267
15 May 2025
Excited to share our work at #BiomedIsrael! Elisha Nathan presents how Immunai de-risks immunotherapy development using AI single-cell multi-omics. Powered by AMICA, the world’s largest clinical immune db. #Immunai #DrugDevelopment #Oncology #Autoimmune
150
5 May 2025
Our CEO @NoamSolomon1 just joined a very impressive club: @INVIVOnow’s 2025 Rising Leaders💥 This list features 30 people shaking up biotech, medtech, and global health.
Proud moment for the @Immunaitech team. bit.ly/4m2eNZm
144
4 May 2025
At #DDW2025, Immunai & @AstraZeneca share new IBD research using single-cell data functional genomics. Deleting one target reduced TNFα/IFNγ in macrophages - showing real therapeutic potential.
📷 Read more: eposters.ddw.org/ddw/2025/dd…
#IBD #Immunology #DrugDiscovery #AIinBiotech
1
179
24 Apr 2025
We’re teaming up with @parkerici to build one of the largest real-world single-cell datasets. Integrated into AMICA™, this will power immune insights across cancers, accelerating discovery reducing trial risk
genengnews.com/topics/cancer…
141
23 Apr 2025
🧬 Heading to #AACR25? Meet Immunai CEO Noam Solomon, CTO Adeeb Rahman, & VP BD Evan Zisholtz
📌 See our April 30 poster on predicting aPD1 response using a human ex vivo tumor model multiomic data.
#Immunotherapy #CancerResearch #Multiomics
152
2 Apr 2025
After leading R&D at Pfizer, Dr. Mikael Dolsten is entering a new chapter. He’s joining Immunai’s board to help advance AI-powered drug development.
Read about his move and outlook on the future of biopharma via @PharmaVoice: tinyurl.com/352t6hxc
1
136
6 Mar 2025
Dr. Mikael Dolsten, a leader behind 35 approved therapies, is bringing his expertise to Immunai’s Board. His experience in R&D and immunology will help us deepen AI’s role in drug discovery, bringing new treatments to patients faster. tinyurl.com/79c4sf4v
2
1,347
4 Feb 2025
🧬 Inside Immunai kicks off 2025 with Eva Macuchova, our Scientific Team Lead! At Immunai, she’s helped standardize data & fuel AI-powered discoveries in cancer & inflammatory research.
Crime novel lover, foodie, & data expert—join her team! tinyurl.com/yck83dwt
181
27 Jan 2025
Immunai has been named Startup of the Week via @theinnovator⭐️
Read how Immunai is bridging the gap between computer science and life sciences to combat Eroom’s Law—the rising costs of drug development.bit.ly/4gbnwEm
3
257
20 Jan 2025
Our CEO @NoamSolomon1 is headed to Davos to represent Immunai as part of the @WEF Unicorn Program with other high-growth companies shaping the future of their industries. Are you attending? tinyurl.com/2mmnvvc3
1
1
156
16 Jan 2025
AI has massive potential in immunotherapies—so why is drug development still lagging?
In @hitconsultant, our CEO, @NoamSolomon1 unpacks data gaps, immune system mapping, and how AI can transform the process. Read: tinyurl.com/2fxnbk2p
1
1
414